Department of Emergency Medicine, Chonnam National University Medical School, Hak Dong 8, Donggu, Gwangju, 501-747, South Korea.
Cardiovasc Toxicol. 2019 Aug;19(4):334-343. doi: 10.1007/s12012-018-09501-w.
To assess myocardial injury related to acute carbon monoxide (CO) poisoning, serial troponin I is measured in patients not presenting with troponin I elevation. This retrospective study investigated whether parameters related to white blood cell (WBC) counts (total and differential WBC counts, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio) improved predictive accuracy for troponin I elevation (> 0.04 ng/ml) in patients not presenting with evidence of myocardial injury. Serial parameters, troponin I values, and clinical courses were collected in 241 patients. Troponin I was elevated in 33 (13.7%) patients after hospitalization. The median lag times to troponin I elevation in patients with undetectable and detectable troponin I (0.015 ng/ml ≤ troponin I ≤ 0.04 ng/ml) at presentation were 5.9 h and 3.0 h, respectively. Patients with troponin I elevation after presentation had higher total WBC and neutrophil counts and NLRs and a lower lymphocyte count during the first 4 h after presentation than patients without troponin I elevation during hospitalization. Total WBC count, neutrophil count, and log NLR at presentation were selected as independent predictive factors for troponin I elevation after presentation. However, only the neutrophil count and log NLR at presentation improved the predictive accuracy in combination with clinical parameters compared with that achieved with a predictive model including only clinical parameters. The optimal cut-off neutrophil count and NLR were 5.21 × 10 /uL and 4.02, respectively. The total neutrophil count and NLR, which are widely available and inexpensive parameters obtained in the emergency department (ED), are promising screening tools for predicting the risk of troponin I elevation in patients without evidence of myocardial injury-related acute CO poisoning at presentation.
为了评估与急性一氧化碳(CO)中毒相关的心肌损伤,在未出现肌钙蛋白 I 升高的患者中连续测量肌钙蛋白 I。这项回顾性研究调查了白细胞(WBC)计数相关参数(总 WBC 计数、分类 WBC 计数、中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值)是否能提高无心肌损伤相关证据的患者肌钙蛋白 I 升高(>0.04ng/ml)的预测准确性。在 241 例患者中收集了连续参数、肌钙蛋白 I 值和临床病程。住院后有 33 例(13.7%)患者肌钙蛋白 I 升高。在入院时肌钙蛋白 I 无法检测到(0.015ng/ml≤肌钙蛋白 I≤0.04ng/ml)和可检测到(0.015ng/ml≤肌钙蛋白 I≤0.04ng/ml)的患者中,肌钙蛋白 I 升高的中位滞后时间分别为 5.9h 和 3.0h。与住院期间无肌钙蛋白 I 升高的患者相比,住院后肌钙蛋白 I 升高的患者在入院后前 4 小时内总白细胞和中性粒细胞计数以及 NLR 更高,淋巴细胞计数更低。入院时总白细胞计数、中性粒细胞计数和 log NLR 被选为入院后肌钙蛋白 I 升高的独立预测因素。然而,与仅包括临床参数的预测模型相比,仅入院时的中性粒细胞计数和 log NLR 与临床参数结合可提高预测准确性。最佳的中性粒细胞计数和 NLR 截断值分别为 5.21×10/uL 和 4.02。总中性粒细胞计数和 NLR 是急诊科广泛可用且价格低廉的参数,是预测无心肌损伤相关急性 CO 中毒患者入院时肌钙蛋白 I 升高风险的有前途的筛查工具。